TY - JOUR
T1 - Subacute kidney injury in hospitalized patients
AU - Fujii, Tomoko
AU - Uchino, Shigehiko
AU - Takinami, Masanori
AU - Bellomo, Rinaldo
PY - 2014/3/7
Y1 - 2014/3/7
N2 - Background and objectives The epidemiology of AKI and CKD has been described. However, the epidemiology of progressively worsening kidney function (subacute kidney injury [s-AKI]) developing over a longer time frame than defined for AKI (7 days), but shorter than defined for CKD (90 days), is completely unknown. Design, setting, participants, &measurements This retrospective study used a hospital laboratory and admission database. Adult patients admitted to a teaching hospital in Tokyo, Japan, between April 1, 2008, and October 31, 2011, were included. s-AKI was classified into three grades of severity (mild, moderate, severe) in accordance with the Risk, Injury, and Failure categories of the Risk, Injury, Failure, Risk, Loss, and ESRD classification, but did not use its time frame. Kidney injury (AKI and s-AKI) occurring during each hospital stay was identified, and logistic regression analysis was performed to assess their effect on hospital mortality. ResultsOf 56,567 patients admitted to the hospital during the study period, 49,518were included. Of these, 87.8% had no evidence of kidney dysfunction, 11.0% had AKI, and 1.1% had s-AKI. Patients with s-AKI hadmild renal dysfunction in 82.7% of cases, moderate in 12.1%, and severe in 5.0%. Worsening s-AKI category was linearly correlatedwith hospitalmortality, as previously described forAKI (no injury: 1.2%,mild: 6.5%, moderate: 12.9%, severe: 20.7%). Although mortality (8.0% versus 17.5%) and need for renal replacement therapy (0.2% versus 2.2%)were lower in patientswith s-AKI than in thosewith AKI,multivariable regression analysis confirmed that s-AKI was an independent risk factor for hospital mortality (odds ratio (OR), 5.44; 95% confidence interval [95% CI], 3.89 to 7.44); the OR with AKI was 14.8 (95% CI, 13.2 to 16.7). Conclusions Close to 1% of hospitalized patients develop s-AKI. This condition is independently associated with increased hospitalmortality, and the risk for death increases with s-AKI severity. Patientswith s-AKI had a better outcome and were less likely to require renal replacement therapy than patients with AKI.
AB - Background and objectives The epidemiology of AKI and CKD has been described. However, the epidemiology of progressively worsening kidney function (subacute kidney injury [s-AKI]) developing over a longer time frame than defined for AKI (7 days), but shorter than defined for CKD (90 days), is completely unknown. Design, setting, participants, &measurements This retrospective study used a hospital laboratory and admission database. Adult patients admitted to a teaching hospital in Tokyo, Japan, between April 1, 2008, and October 31, 2011, were included. s-AKI was classified into three grades of severity (mild, moderate, severe) in accordance with the Risk, Injury, and Failure categories of the Risk, Injury, Failure, Risk, Loss, and ESRD classification, but did not use its time frame. Kidney injury (AKI and s-AKI) occurring during each hospital stay was identified, and logistic regression analysis was performed to assess their effect on hospital mortality. ResultsOf 56,567 patients admitted to the hospital during the study period, 49,518were included. Of these, 87.8% had no evidence of kidney dysfunction, 11.0% had AKI, and 1.1% had s-AKI. Patients with s-AKI hadmild renal dysfunction in 82.7% of cases, moderate in 12.1%, and severe in 5.0%. Worsening s-AKI category was linearly correlatedwith hospitalmortality, as previously described forAKI (no injury: 1.2%,mild: 6.5%, moderate: 12.9%, severe: 20.7%). Although mortality (8.0% versus 17.5%) and need for renal replacement therapy (0.2% versus 2.2%)were lower in patientswith s-AKI than in thosewith AKI,multivariable regression analysis confirmed that s-AKI was an independent risk factor for hospital mortality (odds ratio (OR), 5.44; 95% confidence interval [95% CI], 3.89 to 7.44); the OR with AKI was 14.8 (95% CI, 13.2 to 16.7). Conclusions Close to 1% of hospitalized patients develop s-AKI. This condition is independently associated with increased hospitalmortality, and the risk for death increases with s-AKI severity. Patientswith s-AKI had a better outcome and were less likely to require renal replacement therapy than patients with AKI.
UR - http://www.scopus.com/inward/record.url?scp=84896857799&partnerID=8YFLogxK
U2 - 10.2215/CJN.04120413
DO - 10.2215/CJN.04120413
M3 - Article
C2 - 24311710
AN - SCOPUS:84896857799
SN - 1555-9041
VL - 9
SP - 457
EP - 461
JO - Clinical Journal of the American Society of Nephrology
JF - Clinical Journal of the American Society of Nephrology
IS - 3
ER -